Otros recursos con las palabras clave pharmacy

Resultados 51 - 60 de 923 de pharmacy. (0 segundos)

  1. Microdosing and other phase 0 clinical trials: facilitating translation in Drug Development (�)

    Burt, T.; Yoshida, K.; Lappin, G.; Vuong, L.; John, C.; de Wildt, S. N.; Sugiyama, Y.; Rowland, M.
    Increasing costs of drug development and ethical concernsabout the risks of exposing humans and anim ...
    (application/pdf) 29-ago-2017

  2. Microcrystalline testing used in combination with Raman micro-spectroscopy for absolute identification of novel psychoactive substances (�)

    Elie, Leonie; Elie, Mathieu; Cave, Gareth; Vetter, Marleen; Croxton, Ruth; Baron, Mark
    Two new psychoactive substances, namely 4-methylmethcathinone (mephedrone) and 5,6-methylenedioxy-2- ...
    (application/pdf) 29-ago-2017

  3. Approaches to intravenous clinical pharmacokinetics: recent developments with isotopic microtracers (�)

    Lappin, Graham
    Obtaining pharmacokinetic data from the intravenous route for drugs intended for oral administration ...

  4. Effect on hypnotic prescribing of a quality improvement collaborative for primary care of insomnia: segmented regression analysis (�)

    Smith, Murray D.; Siriwardena, Niro
    Introduction Patients with insomnia commonly present to general practice. Hypnotic misuse and underu ...
    (application/pdf) 29-ago-2017

  5. A simple approach to predict the stability of phospholipid vesicles to nebulization without performing aerosolization studies (�)

    Subramanian, S.; Khan, I.; Korale, O.; Alhnan, M. A.; Ahmed, W.; Najlah, M.; Taylor, K. M. G.; Elhissi, A.
    Membrane extrusion was investigated for predicting the stability of soya phosphatidylcholine liposom ...

  6. Effects of ecstasy on autobiographical memories: implications for MDMA assisted psychotherapy (�)

    Curran, HV; Wall, M; Demetriou, L; Carhart-Harris, R; Fergusson, B; Nutt, D

  7. Downstream Processing for Cell-Based Therapies (�)

    Rafiq, QA; Masri, F

  8. Potential involvement of a CLSTN3 variant in susceptibility to schizophrenia (�)

    Al Eissa, M; Fiorentino, A; Sharp, S; O'Brien, NL; Giaroli, G; Wolf, K; Bass, NJ; McQuillin, A; Curtis, D

  9. Neuropsychopharmacology in human cannabis users: findings from molecular imaging (�)

    Bloomfield, M; Howes, O; Ashok, A; Volkow, N


    Mazzari, ALDA; Frangos, S; Silveira, D; Rocha Neves, FDA; Milton, F; Carvalho, AC; Prieto, JM

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.